Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 9, 2008, Pages 3976-3980

  Ozaki, Mineo ^a   Lee, Kelvin Y C ^b   Vithana, Eranga N ^b   Yong, Victor H ^b   Thalamuthu, Anbupalam ^c   Mizoguchi, Takanori ^d   Venkatraman, Anandalakshmi ^b   Aung, Tin ^b,e  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

^d Mizoguchi Eye Clinic   (Japan)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; LYSYL OXIDASE LIKE 1; PROTEIN LYSINE 6 OXIDASE; UNCLASSIFIED DRUG; DNA; LOXL1 PROTEIN, HUMAN; OXIDOREDUCTASE;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; DNA SEQUENCE; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; GLAUCOMA; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOEXFOLIATION; PSEUDOEXFOLIATION GLAUCOMA; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; BLOOD; EXFOLIATION SYNDROME; GENETIC POLYMORPHISM; GENETICS; JAPAN; MIDDLE AGED; REFERENCE VALUE; SEXUAL DEVELOPMENT;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID OXIDOREDUCTASES; ASIAN CONTINENTAL ANCESTRY GROUP; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXFOLIATION SYNDROME; FEMALE; HAPLOTYPES; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; SEX CHARACTERISTICS;

EID: 53149112354     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-1805     Document Type: Article

References (32)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844-851.
2. Tarkkanen A, Kivela T, John G. Lindberg and the discovery of exfoliation syndrome. Acta Ophthalmol Scand. 2002;80(2):151-154.
3. Ritch R. Exfoliation syndrome and occludable angles. Trans Am Ophthalmol Soc. 1994;92:845-944.
4. Ringvold A. Epidemiology of the pseudo-exfoliation syndrome. Acta Ophthalmol Scand. 1999;77(4):371-375.
5. Arnarsson A, Damji KF, Sverrisson T, Sasaki H, Jonasson F. Pseudo-exfoliation in the Reykjavik Eye Study: prevalence and related ophthalmological variables. Acta Ophthalmol Scand. 2007;85(8):822-827. (Pubitemid 350142802)
6. Forsius H. Prevalence of pseudoexfoliation of the lens in Finns, Lapps, Icelanders, Eskimos and Russians. Trans Ophthalmol Soc UK. 1979;99(2):296-298. (Pubitemid 10074872)
7. Mitchell P, Wang JJ, Hourihan F. The relationship between glaucoma and pseudoexfoliation: The Blue Mountains Eye Study. Arch Ophthalmol. 1999;117(10):1319-1324. (Pubitemid 30029342)
8. Yamamoto T, Iwase A, Araie M, et al. The Tajimi Study Report No. 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology. 2005;112(10):1661-1669.
9. Miyazaki M, Kubota T, Kubo M, et al. The prevalence of pseudo-exfoliation syndrome in a Japanese population: the Hisayama Study. J Glaucoma. 2005;14(6):482-484. (Pubitemid 41682243)
10. Naumann GO, Schlötzer-Schrehardt U, Küchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist: intraocular and systemic manifestations. Ophthalmology. 1998;105(6):951-968. (Pubitemid 28268316)
11. Mitchell P, Wang JJ, Smith W. Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol. 1997;124(5):685-687. (Pubitemid 27469246)
12. Ringvold A. Pseudoexfoliation and aortic aneurysms. Lancet. 2001;357(9274):2139-2140.
13. Roedl JB, Bleich S, Reulbach U, et al. Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma. J Neural Transm. 2007;114(5):571-575. (Pubitemid 46664043)
14. Atalar PT, Atalar E, Kilic H, et al. Impaired systemic endothelial function in patients with pseudoexfoliation syndrome. Int Heart J. 2006;47(1):77-84. (Pubitemid 43316730)
15. Visontai Z, Merisch B, Kollai M, Hollo G. Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma. Br J Ophthalmol. 2006;90(5):563-567.
16. Jeng SM, Karger RA, Hodge DO, Burke JP, Johnson DH, Good MS. The risk of glaucoma in pseudoexfoliation syndrome. J Glaucoma. 2007;16(1):117-121.
17. Schlötzer-Schrehardt U, Naumann GO. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol. 2006;141(5):921-937.
18. Schlötzer-Schrenhardt U, Naumann GO. Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma: a morphometric, ultrastructural study. Invest Ophthalmol Vis Sci. 1995;36(9):1750-1764.
19. Hewitt AW, Craig E, Mackey DA. Complex genetics of complex traits: the case of primary open-angle glaucoma. Clin Exp Ophthalmol. 2006;34(5):472-484.
20. Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317(5843):1397-1400. (Pubitemid 47417481)
21. Hewitt AW, Sharma S, Burdon KP, et al. Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum Mol Genet. 2008;17(5):710-716. (Pubitemid 351292259)
22. Fingert JH, Alward WL, Kwon YH, et al. LOXL1 mutations are associated with exfoliation syndrome in patients from the Midwestern United States. Am J Ophthalmol. 2007;144(6):974-975.
23. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at http://www.R-project.org;2007. Accessed December 30, 2007.
24. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575. (Pubitemid 47330214)
25. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263-265. (Pubitemid 40202029)
26. Purcell S, Daly MJ, Sham PC. WHAP: haplotype-based association analysis. Bioinformatics. 2007;23(2):255-256.
27. Feder JN, Gnirke A, Thomas W, Tsuchihasi Z. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408. (Pubitemid 26256612)
28. Nielsen DM, Ehm MG, Weir BS. Detecting marker-disease association by Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet. 1999;63:1531-1540.
29. Hayashi H, Gotoh N, Ueda Yoshiki, et al. Lysyl Oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese Population. Am J Ophthalmol. 2008;145(3):582-585.
30. Liu X, Zhao Y, Gao J, et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet. 2004;36(2):178-182. (Pubitemid 38174378)
31. Lucero HA, Kagan HM. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci. 2006;63(19-20):2304-2316.
32. Thomassin L, Werneck CC, Broekelmann TJ, et al. The pro-regions of lysyl oxidase and lysyl oxidase-like 1 are required for deposition onto elastic fibers. J Biol Chem. 2005;280(52):42848-42855. (Pubitemid 43049247)